Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Fine & Speciality Chemicals
Return to: PBR Home | Production & Manufacturing | Fine & Speciality Chemicals

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News INVISTA, SilicoLife to develop new technologies for bio-derived processes By PBR Staff Writer
INVISTA and SilicoLife, a computational biology company, have collaborated to develop new technologies that facilitate bio-derived processes for the production of industrial chemicals.
Production & Manufacturing > Fine & Speciality Chemicals > News
See more Fine & Speciality Chemicals news

Latest Fine & Speciality Chemicals News and Insight

View all Fine & Speciality Chemicals news or find news targeted to your interests
Almac Discovery Announce key Wee-1 kinase patent approval
Inhibitors of Wee-1 kinase, cell cycle regulator, have potential for clinical utility across a broad range of cancer indications
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Almac Group Announces Publication of Prostate Cancer Metastatic Assay Validation
Almac Group’s Diagnostics business unit today announced the Journal of European Urology has published results relating to its Prostate Cancer Metastatic Assay. The publication demonstrates the assay can be used to analyse primary prostate cancer FFPE samples to identify a molecular subgroup with a high risk of developing distant metastases. The assay therefore has the potential to guide the choice of therapy for patients presenting with primary prostate cancer.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Almac Diagnostics and EORTC Establish Collaboration for Tumour Molecular Profiling
Partnership to support the discovery and development of novel biomarkers, enabling personalised medicine
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Novo Nordisk Pharmatech enters important distribution agreement with Azelis for pharmaceutical grade quaternary ammonium compounds
Novo Nordisk Pharmatech A/S has entered into an agreement with Azelis for the distribution of pharmaceutical grade quaternary ammonium compounds (quats) to the pharmaceutical and medical device markets in Germany, Spain Portugal, UK and Ireland.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
WeylChem Group of Companies. Better chemistry – achieving more.
WeylChem Group of Companies (WCGC) was established in 2005 as the Fine Chemicals platform of International Chemical Investors Group (ICIG), a privately owned industrial holding company. We are a specialised service provider to the agrochemical, pharmaceutical, polymer and specialty chemicals industries, offering custom-, toll-manufacturing as well as advanced intermediates, reagents and performance products.
Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
A Survival Guide to Temperature Data in Life Sciences, by Almac
| By Almac
Regulations continue to evolve globally within the distribution arena of the Life Sciences industry. Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01)1 as well as Good Distribution Practices Supply Chain Integrity2 has made the most significant impact. There is an increased focus on companies being able to prove the quality and integrity of their drug product throughout the entire supply chain. The industry is facing stricter compliance demands from regulations and regulatory agencies are not always given clear guidance.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Almac: Changing the Dynamics of Temperature Controlled Shipping Solutions
| By Almac
In the typical clinical trial today, the cost of shipping and distributing supplies accounts for approximately 60 percent of the overall clinical supply chain. And when the cost of product spoilage from temperature excursions is added into the mix, it is no wonder that pharmaceutical companies, Clinical Research Organizations (CROs), and logistics vendors are all eagerly searching for efficiencies and ways to carve costs out of the process.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Almac Explores Interactive Response Technology: An Untapped Source of Historical and Real-Time Data for Risk-Based Monitoring
| By Almac
Risk-based monitoring has attracted the support of a diverse group of organisations in recent years. Regulators have released guidance encouraging the use of risk-based approaches to clinical trial quality, vendors have created technologies to support such methods, and large pharma companies have pooled their resources to drive adoption. Yet, despite this flurry of activity, the industry has overlooked a potentially useful source of real-time and historical data.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
View all Fine & Speciality Chemicals news or find news targeted to your interests